<Header>
<FileStats>
    <FileName>20161214_10-K-A_edgar_data_849146_0000849146-16-000213_1.txt</FileName>
    <GrossFileSize>47251</GrossFileSize>
    <NetFileSize>7489</NetFileSize>
    <ASCII_Embedded_Chars>0</ASCII_Embedded_Chars>
    <HTML_Chars>35362</HTML_Chars>
    <XBRL_Chars>0</XBRL_Chars>
    <XML_Chars>0</XML_Chars>
    <N_Tables>3</N_Tables>
    <N_Exhibits>2</N_Exhibits>
</FileStats>
<SEC-Header>
0000849146-16-000213.hdr.sgml : 20161214
<ACCEPTANCE-DATETIME>20161214162418
ACCESSION NUMBER:		0000849146-16-000213
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160630
FILED AS OF DATE:		20161214
DATE AS OF CHANGE:		20161214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		162051347

	BUSINESS ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406

</SEC-Header>
</Header>

 0000849146-16-000213.txt : 20161214

10-K/A
 1
 a10-k_afy2016.htm
 10-K/A

Document 

UNITED STATES 
  SECURITIES AND EXCHANGE COMMISSION 
  WASHINGTON, D.C. 20549 
  ________________________________________________ 
  Amendment No. 1 to  
  FORM 10-K 
  (Mark One) 

For the fiscal year ended June 30, 2016 

For the transition period from                      to 
  Commission file number: 001-35647 
  ________________________________________________ 
  LIFEVANTAGE CORPORATION 
  (Exact name of registrant as specified in its charter) 

Securities registered pursuant to Section 12(b) of the Act: None 
  Securities registered pursuant to Section 12(g) of the Act: 
  Common Stock, $0.001 par value per share 
  (Title of Class) 
  ________________________________________________ 
  Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes           No      
  Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes           No      
  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant  

was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes           No      
  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes           No      
  Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.      
  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of  large accelerated filer,   accelerated filer  and  smaller reporting company  in Rule 12b-2 of the Exchange Act. (Check one): 
                     Large accelerated filer 
      
    Accelerated filer 
      
      Non-accelerated filer 
        (Do not check if a smaller reporting company) 
    Smaller reporting company 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes           No      
  The aggregate market value of the registrant's common stock held by non-affiliates as of December, 31, 2015, the end of the registrant's second fiscal quarter, was approximately $133.2 million, based on a closing market price of $9.52 per share.  
  The number of shares of common stock (par value $0.001) outstanding as of November 30, 2016, was 14,057,722 shares. 
  ________________________________________________ 
  DOCUMENTS INCORPORATED BY REFERENCE 
  None.  

Explanatory Note  
  LifeVantage Corporation (the  Company,   we,   us,  or  our ) is filing this Amendment No. 1 on Form 10-K/A (this  Amendment ) to its annual report on Form 10-K for the fiscal year ended June 30, 2016, which was originally filed on December 12, 2016 (the  Original Filing ).    This Amendment is being filed solely to amend the certifications by our Chief Executive Officer (principal executive officer) and our Chief Financial Officer (principal financial officer), which were filed as Exhibits 32.1 and 32.2 to the Original Filing, which inadvertently referenced an incorrect date.      The corrected certifications are filed as Exhibits 32.1 and 32.2 to this Amendment.    This Amendment does not reflect events occurring after the date of the Original Filing and, other than the re-filing of the referenced certifications, does not modify or update the disclosures in the Original Filing in any way. 

PART IV 
    
  ITEM 15   EXHIBITS, FINANCIAL STATEMENT SCHEDULES 
  The following documents are being filed as part of this report: 
    
  Exhibits 
  See the Exhibit Index following the signature page of this report. 

SIGNATURE 
    
  Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

LifeVantage Corporation. 
  a Colorado corporation 

By: 
    /s/    Mark Jaggi 
        
    Mark Jaggi 
      Its: 
    Chief Financial Officer 
      Date: 
    December 14, 2016 

EXHIBIT INDEX 
                       Exhibit 
  No. 
      
    Document Description 
      
    Filed Herewith or Incorporated by Reference From 

32.1 
      
    Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 
      
    Furnished herewith. 

32.2 
      
    Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 
      
    Furnished herewith. 

<EX-32.1>
 2
 ex321ceosec906certificatio.htm
 EXHIBIT 32.1

Exhibit 

EXHIBIT 32.1 
  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED 
  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 
  In connection with the filing of this annual report on Form 10-K of LifeVantage Corporation (the  Company ) for the period ended June 30, 2016, with the Securities and Exchange Commission on the date hereof (the  Report ), I, Darren Jensen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 
           1. 
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 
              2. 
    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 
                    December 14, 2016 
    /s/ Darren Jensen 
        
    Darren Jensen 
  President   Chief Executive Officer 
  (Principal Executive Officer) 

</EX-32.1>

<EX-32.2>
 3
 ex322cfosec906certificatio.htm
 EXHIBIT 32.2

Exhibit 

EXHIBIT 32.2 
  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED 
  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 
  In connection with the filing of this annual report on Form 10-K of LifeVantage Corporation (the  Company ) for the period ended June 30, 2016, with the Securities and Exchange Commission on the date hereof (the  Report ), I, Mark Jaggi, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 
           1. 
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 
              2. 
    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.    
                    December 14, 2016 
    /s/ Mark Jaggi 
        
    Mark Jaggi 
  Chief Financial Officer 
  (Principal Financial Officer) 

</EX-32.2>

